Prescription Medication Insights
Semaglutide for MASH: What the ESSENCE Trial Showed and Who the Approval Covers
Straight answer Semaglutide has shown a meaningful benefit in MASH, the inflammatory form of metabolic fatty liver disease. In the phase 3 ESSENCE trial,…